Fundraising Fox
/Companies
Sign in

Biomakers

City Of Dover, County Of Kent, US · Delaware corporation · 5 known investors

Find your way into Biomakers

Sign up to see every warm intro you have to Biomakers

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Biomakers team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Biomakers operates a precision oncology platform that combines genomic testing, clinical data, biobanking, and AI to support cancer care and drug and diagnostic development. It focuses on expanding access to cancer care across Latin America while generating clinical and biospecimen data.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtech

Founders & leadership

NKNicolas Kirchuk
Nicolas KirchukCEO & Co-FounderNicolas Kirchuk is co-founder and CEO of Biomakers, a precision oncology company that develops genomic testing, real-world data platforms, and AI tools for cancer diagnosis, treatment, and drug development across Latin America. He was recognized by Forbes as an outstanding young entrepreneur in 2018 and has led Biomakers to establish sequencing facilities in Mexico, Brazil, and Argentina.
RJ
Ruben Javier SalanovaNamed on SEC filing
JM
Juan Manuel MarroneSecretary

Board

CVConsuelo Valverde
Consuelo ValverdeMember Board Of DirectorsFounder and Managing Partner at Endurance28
PF
Pablo FernandezBoard director
CD
Clarisa Diana LifsicDirector, Treasurer

Investors · 5

SV Latam Capitallisted by SV Latam CapitalSan Francisco · $50K – $500K

How we know: SV Latam Capital's portfolio page · Not right? Tell us

Zentynel Frontier Investmentslisted by Zentynel Frontier InvestmentsSantiago

How we know: Zentynel Frontier Investments's portfolio page · Not right? Tell us

Alpha PartnersreportedNew York · $3M – $10M

How we know: a partner's Signal profile · Not right? Tell us

SV Latam FundreportedSan Francisco

How we know: a partner's Signal profile · Not right? Tell us

Funding

SEC filings, press & company announcements

$13.9M disclosed across 2 rounds · 2024–2026

▶$5.9MraisedApr 2026 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ruben Javier SalanovaDirector
  • Pablo FernandezDirector
  • Juan Manuel MarroneExecutive Officer
  • Consuelo ValverdeDirector
  • Clarisa Diana LifsicExecutive Officer, Director
  • Nicolas KirchukExecutive Officer, Director
Offering amount
$8M
Amount sold
$5.9M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Biomakers do?
Biomakers operates a precision oncology platform that combines genomic testing, clinical data, biobanking, and AI to support cancer care and drug and diagnostic development. It focuses on expanding access to cancer care across Latin America while generating clinical and biospecimen data.
Who founded Biomakers?
Biomakers was founded by Nicolas Kirchuk.
Who are Biomakers's investors?
Biomakers's investors include Oncology Ventures, SV Latam Capital, Zentynel Frontier Investments, Alpha Partners, SV Latam Fund.
How much funding has Biomakers raised?
Biomakers has disclosed $13.9M raised across 2 rounds.
Where is Biomakers headquartered?
Biomakers is headquartered in City Of Dover, County Of Kent, US.